Campbell Gordon has joined Ophthalmic Instrument Company (OIC) as national product specialist looking after diagnostic equipment and software across ophthalmology and optometry. Gordon, previously
Australasian-based Optimed has partnered with Essilor Instruments to deliver diagnostic, refraction and finishing solution services across New Zealand and Australia.
Ophthalmic equipment company Designs for Vision (DFV) has appointed Jonathan Spencer as its new surgical territory manager for New Zealand.
Dubbed ‘a critical step in the basic understanding of how humans see’, research from UCLA Jules Stein Eye Institute reveals a molecular pathway that helps our eyes see continuously in bright light.
Well-known to the New Zealand ophthalmic technology market, Chris Money has recently joined Glaukos as senior regional business manager.
BHVI has announced it is 'embarking on a new strategic roadmap', with an organisational restructure and a new managing director of its science arm VisionCRC on board.Dr Arthur Back, formerly of
First steps are being made by the Ministry of Health towards establishing its new Health Infrastructure Unit to support and oversee the building of new clinical facilities in New Zealand, with two new
A clinical trial comparing methotrexate and the more expensive mycophenolate mofetil treating non-infectious uveitis shows the two drugs offer very similar results.
Aussiedex phase IV results trialling Ozurdex (dexamethasone) intravitreal implant in patients with diabetic macular oedema (DME) echo existing evidence that Ozurdex is a safe and effective treatment
Researchers from École Polytechnique Fédérale de Lausanne in Switzerland and Scuola Superiore Sant’Anna in Italy have developed a new type of intraneural electrode that bypasses the eyeball entirely
A retrospective review found low-level light therapy (LLLT) successfully resolved recalcitrant chalazia in most patients who failed topical or systemic therapy, significantly reducing the need for
Researchers at SUNY Downstate Health Sciences University in Brooklyn are working on a science fiction-esque optogenetic technology to give blind people the ability to see. The OBServ visual
